Advances in the first-line treatment of ES-SCLC: From clinical data to daily practice

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading lung cancer experts share their perspectives on recent advances in the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) and how they are changing clinical practice. The experts Dr Marina Garassino - University of Chicago, Chicago, IL, USA Dr Louis Paz-Ares - Hospital Universitario 12 de Octubre, Complutense University and Ciberonc, Madrid, Spain DR Martin Edelman - Fox Chase Cancer Center, Philadelphia, PA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncology.com/ES-SCLC-first-line-treatment